Literature DB >> 30100583

Guidance on the management of familial hypercholesterolaemia in Hong Kong: an expert panel consensus viewpoin.

B Tomlinson1, J Cn Chan1, W B Chan2, W Wc Chen3, F Cc Chow1, S K Li4, A Ps Kong1, R Cw Ma1, D Cw Siu5, K Cb Tan5, L Ks Wong1, V Tf Yeung6, B Wm But7, P T Cheung8, C C Fu9, J Yl Tung10, W C Wong11, H C Yau12.   

Abstract

In 2016, meetings of groups of physicians and paediatricians with a special interest in lipid disorders and familial hypercholesterolaemia were held to discuss several domains of management of familial hypercholesterolaemia in adults and children in Hong Kong. After reviewing the evidence and guidelines for the diagnosis, screening, and management of familial hypercholesterolaemia, consensus was reached on the following aspects: clinical features, diagnostic criteria, screening in adults, screening in children, management in relation to target plasma low-density lipoprotein cholesterol levels, detection of atherosclerosis, lifestyle and behaviour modification, and pharmacotherapy.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30100583     DOI: 10.12809/hkmj187215

Source DB:  PubMed          Journal:  Hong Kong Med J        ISSN: 1024-2708            Impact factor:   2.227


  3 in total

1.  Synthesis of Chemically Cross-Linked pH-Sensitive Hydrogels for the Sustained Delivery of Ezetimibe.

Authors:  Rahima Khan; Muhammad Zaman; Ahmad Salawi; Mahtab Ahmad Khan; Muhammad Omer Iqbal; Romana Riaz; Muhammad Masood Ahmed; Muhammad Hammad Butt; Muhammad Nadeem Alvi; Yosif Almoshari; Meshal Alshamrani
Journal:  Gels       Date:  2022-05-01

2.  Role of PCSK9 Inhibitors in Patients with Familial Hypercholesterolemia.

Authors:  Brian Tomlinson; Nivritti Gajanan Patil; Manson Fok; Christopher Wai Kei Lam
Journal:  Endocrinol Metab (Seoul)       Date:  2021-04-19

Review 3.  Familial Hypercholesterolemia in Asia Pacific: A Review of Epidemiology, Diagnosis, and Management in the Region.

Authors:  Sanjay Kalra; Zhenyue Chen; Chaicharn Deerochanawong; Kou-Gi Shyu; Ru San Tan; Brian Tomlinson; Hung-I Yeh
Journal:  J Atheroscler Thromb       Date:  2021-03-19       Impact factor: 4.928

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.